Signal Advisors Wealth, LLC Intellia Therapeutics, Inc. Transaction History
Signal Advisors Wealth, LLC
- $698 Billion
- Q3 2024
A detailed history of Signal Advisors Wealth, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Signal Advisors Wealth, LLC holds 46,376 shares of NTLA stock, worth $747,117. This represents 0.14% of its overall portfolio holdings.
Number of Shares
46,376Holding current value
$747,117% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
311Shares Held
89.8MCall Options Held
624KPut Options Held
849K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$197 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$155 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$77.3 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$70.3 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.22B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...